EGFR Tyrosine Kinase Inhibitors Prolong Overall Survival in EGFR Mutated Non-Small-Cell Lung Cancer Patients with Postsurgical Recurrence . (2012). Journal of Cancer Research Updates, 1(1),  102-107. https://doi.org/10.6000/1929-2279.2012.01.01.15